NCT04809311 - Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

January 7, 2025

Study Completion Date

January 7, 2025

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Oral antidiabetetic drugs

"During the study, no medical drugs will be supplied to the patients. Patients will continue their antidiabetic treatment independently of this study and at the treating physician's discretion as part of usual clinical practice.~Approximately 12-week study duration"

DRUG

Basal insulin

"During the study, no medical drugs will be supplied to the patients. Patients will continue their antidiabetic treatment independently of this study and at the treating physician's discretion as part of usual clinical practice.~Approximately 12-week study duration"

DRUG

Glucagon-like peptide-1 (GLP-1)

"During the study, no medical drugs will be supplied to the patients. Patients will continue their antidiabetic treatment independently of this study and at the treating physician's discretion as part of usual clinical practice.~Approximately 12-week study duration"

Trial Locations (1)

Unknown

Digital/virtual site, Copenhegan